Location · Minnesota
Clinical trials recruiting in Minnesota
563 recruiting studies have at least one site in Minnesota; 223 accept healthy volunteers. Studies that need a specific condition are included too, so check each listing.
Want the research companies that run paid Phase 1 studies for healthy volunteers? Paid clinical trial companies in Minnesota.
563 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 2
A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
Corxel Pharmaceuticals
- Location
- Edina, MN + 32 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Edwards Lifesciences
- Location
- Rochester, MN + 44 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
DiaMedica Therapeutics Inc
- Location
- Minneapolis, MN + 35 other US sites
- Eligibility basics
- Ages 18–90
- RecruitingPhase 3
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
AbbVie
- Location
- Burnsville, MN + 87 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 3
A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections.
Basilea Pharmaceutica
- Location
- Minneapolis, MN + 18 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
Regeneron Pharmaceuticals
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18–60
- RecruitingPhase 3
Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Vega Therapeutics, Inc
- Location
- Minneapolis, MN + 13 other US sites
- Eligibility basics
- Ages 12–75
- RecruitingPhase 2
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Beijing InnoCare Pharma Tech Co., Ltd.
- Location
- New Brighton, MN + 13 other US sites
- Eligibility basics
- Ages 18–75
- Recruiting
Cephea Early Feasibility Study
Abbott Medical Devices
- Location
- Minneapolis, MN + 19 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1/Phase 2
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
COUR Pharmaceutical Development Company, Inc.
- Location
- Minneapolis, MN + 44 other US sites
- Eligibility basics
- Ages 12–35
- RecruitingPhase 2
Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
XyloCor Therapeutics, Inc.
- Location
- Minneapolis, MN + 12 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingPhase 2
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
ONL Therapeutics
- Location
- Rochester, MN + 55 other US sites
- Eligibility basics
- Ages 55+
- RecruitingPhase 3
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Cardiol Therapeutics Inc.
- Location
- Minneapolis, MN + 20 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Efficacy and Safety of Intranasal Cenegermin in Adult Participants With Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)
Dompé Farmaceutici S.p.A
- Location
- Rochester, MN + 13 other US sites
- Eligibility basics
- Ages 50–80
- RecruitingPhase 3
A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Takeda
- Location
- Minneapolis, MN + 9 other US sites
- Eligibility basics
- Up to age 17
- Recruiting
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
BrioHealth Solutions, Inc.
- Location
- Minneapolis, MN + 46 other US sites
- Eligibility basics
- Ages 18–100
- RecruitingPhase 3
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
AstraZeneca
- Location
- Minneapolis, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
Eli Lilly and Company
- Location
- Minneapolis, MN + 28 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingPhase 1
Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement
Harvard Apparatus Regenerative Technology, Inc.
- Location
- Rochester, MN + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
AstraZeneca
- Location
- Saint Cloud, MN + 53 other US sites
- Eligibility basics
- Ages 40–80
- RecruitingPhase 1/Phase 2
ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome
Ionis Pharmaceuticals, Inc.
- Location
- Rochester, MN + 4 other US sites
- Eligibility basics
- Ages 2–12
- RecruitingPhase 3
Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Verrica Pharmaceuticals Inc.
- Location
- New Brighton, MN + 5 other US sites
- Eligibility basics
- Ages 2+
- Recruiting
The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
SetPoint Medical Corporation
- Location
- Plymouth, MN + 8 other US sites
- Eligibility basics
- Ages 22–60
- Recruiting
Chronic Evaluation of Novel Pacemaker System
Calyan Technologies
- Location
- Minneapolis, MN
- Eligibility basics
- Ages 18+